Rush University Medical Center Rush 3 — Chicago, Illinois

Rush University Medical Center Rush 3 is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Rush University Medical Center Rush 3 has participated in 1 clinical trials.

Therapeutic areas: Advanced Solid Tumors, Excluding Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush University Medical Center Rush 3?

Rush University Medical Center Rush 3 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush University Medical Center Rush 3 conducted?

Rush University Medical Center Rush 3 has 1 clinical trials on record. Their work covers Advanced Solid Tumors, Excluding Breast Cancer.

Is Rush University Medical Center Rush 3 accredited by Crixeo Health?

Rush University Medical Center Rush 3 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush University Medical Center Rush 3?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.